Praxis Precision Medicines: Nonetheless Potential Upside After Large Rally (NASDAQ:PRAX)
Bret Jensen has been investing for the reason that Nineteen Eighties. He has been writing for Actual Cash Professional and Searching for Alpha since 2010. Bret makes a speciality of excessive beta sectors with doubtlessly massive investor returns.Bret leads the investing group The Biotech Discussion board, through which he and his group supply a mannequin portfolio with their favourite 12-20 excessive upside biotech shares, stay chat to debate commerce concepts, and weekly analysis and choice trades. The group additionally offers market commentary, and a portfolio replace each weekend. Be taught Extra.
Analyst’s Disclosure: I/now we have a useful lengthy place within the shares of PRAX both by inventory possession, choices, or different derivatives. I wrote this text myself, and it expresses my very own opinions. I’m not receiving compensation for it (apart from from Searching for Alpha). I’ve no enterprise relationship with any firm whose inventory is talked about on this article.
Searching for Alpha’s Disclosure: Previous efficiency is not any assure of future outcomes. No advice or recommendation is being given as as to whether any funding is appropriate for a specific investor. Any views or opinions expressed above could not replicate these of Searching for Alpha as an entire. Searching for Alpha is just not a licensed securities vendor, dealer or US funding adviser or funding financial institution. Our analysts are third get together authors that embrace each skilled traders and particular person traders who might not be licensed or licensed by any institute or regulatory physique.
